Trial Profile
Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea: Double Blinded, Randomized, Placebo Drug Controlled, Parallel Designed, Multi-centered, Phase 2 Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Bacillus subtilis/enterococcus faecium/mosapride (Primary) ; Probiotics
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 21 May 2013 Results presented at the Digestive Disease Week 2013.
- 13 Jan 2012 New trial record